Association between antecedent statin use and severe disease outcomes in COVID-19: A retrospective study with propensity score matching

Metabolic Syndrome and clinical outcomes in patients infected with COVID ‐19: Does age, sex and race of the patient with Metabolic Syndrome matter?

(2021) Prateek Lohia et al.   Journal of Diabetes

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China

(2020) Ruchong Chen et al.   CHEST

Post‐mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction

(2020) T. Menter et al.   HISTOPATHOLOGY

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

(2020) Jing Yang et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

(2020) Matt Arentz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

(2020) Zhaohai Zheng et al.   JOURNAL OF INFECTION

Acute kidney injury in patients hospitalized with COVID-19

(2020) Jamie S. Hirsch et al.   KIDNEY INTERNATIONAL

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Considerations for Statin Therapy in Patients with COVID‐19

(2020) Simin Dashti‐Khavidaki et al.   PHARMACOTHERAPY

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection

(2020) David S. Fedson et al.   mBio

Statin therapy in COVID-19 infection

(2020) Vincenzo Castiglione et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Meta-analysis of Effectiveness of Statins in Patients with Severe COVID-19

(2020) Chia Siang Kow et al.   AMERICAN JOURNAL OF CARDIOLOGY

Statins: Could an old friend help in the fight against COVID‐19?

(2020) Raul R. Rodrigues‐Diez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science

(2020) Paul C Evans et al.   CARDIOVASCULAR RESEARCH

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

(2020) Xiao-Jing Zhang et al.   Cell Metabolism

Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression

(2020) Raymond Pranata et al.   Journal of Stroke & Cerebrovascular Diseases

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

(2020) Giacomo Grasselli et al.   Lancet Respiratory Medicine

Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus

(2019) Donna Episcopio et al.   FASEB JOURNAL

Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome*

(2019) Angela J. Rogers et al.   CRITICAL CARE MEDICINE

Immune modulatory effects of statins

(2018) Robert Zeiser   IMMUNOLOGY

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing

(2018) Punya Shrivastava-Ranjan et al.   mBio

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

(2018) Carolyn S Calfee et al.   Lancet Respiratory Medicine

Treating Ebola patients: a ‘bottom up’ approach using generic statins and angiotensin receptor blockers

(2015) David S. Fedson et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection: FIG 1 

(2015) Shu Yuan   mBio

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

(2015) Allison L. Totura et al.   mBio

Simvastatin in the Acute Respiratory Distress Syndrome

(2014) Daniel F. McAuley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Treating influenza with statins and other immunomodulatory agents

(2013) David S. Fedson   ANTIVIRAL RESEARCH

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Inhibition of NF- B-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival

(2013) M. L. DeDiego et al.   JOURNAL OF VIROLOGY

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells

(2012) A.-K. Hechinger et al.   HAEMATOLOGICA